Latest Industry Insights

Structure verification by NMR is a vital task in drug discovery but can be slow and subjective. This article explores how ASV transforms it into a scalable, consistent and reliable process.

Anti-infective discovery is evolving with AI and robotics – learn how UK researchers aim to cut development time and improve success rates.

We spoke with the developers and manufacturers of the CRISPR gene therapy used to treat KJ Muldoon’s rare genetic condition, CPS1, about how the product was created in just six months.

Novo Nordisk’s Transformational Prevention Unit (TPU) integrates AI, omics, and genomics to predict obesity risk and tailor interventions. By focusing on personalized solutions, TPU aims to prevent obesity and reduce the incidence of related diseases

Explore the clinical impact of accurate vitamin D measurement, how the cobas® Mass Spec solution enhances diagnostic precision and the broader role of clinical mass spectrometry in advancing personalized healthcare.

Chromatography-free mass spectrometry boosts throughput, cuts costs and simplifies drug monitoring – learn how Bruker and RECIPE are leading the way.

In this interview, Morten Bern, chief executive officer of Evosep, discusses the innovations behind the Eno system, the evolving needs of pharmaceutical customers and the growing focus on high-throughput, high-sensitivity proteomics solutions.

In this interview, we explore how Cerno’s vendor-neutral software solutions enhance mass spectrometry data analysis.

Unlike injectable weight loss drugs that often serve as a temporary fix, Elcella seeks to naturally activate the gut’s own appetite-regulating mechanisms, offering a new path to long-term health and sustainable weight management.

Seer joined Technology Networks for a conversation about its new Proteograph® Product Suite at ASMS 2025.